Health Equity in the Era of Free Trade Agreements: A Scoping Review of Mechanisms, Evidence, and Policy Options
DOI:
https://doi.org/10.47203/IJCH.2025.v37i04.015Keywords:
Free trade agreements, Health equity, Intellectual property, Investor–state dispute settlement, Noncommunicable diseases, TRIPS flexibilities, Vaccine equity, Health impact assessmentAbstract
Background: Modern free trade agreements (FTAs) extend beyond tariffs to include intellectual property (IP), investment rules, and regulatory standards that influence social determinants of health and equity. Understanding these mechanisms is critical for safeguarding public health. Aims & Objectives: To synthesise evidence on the health equity implications of FTAs and identify priority policy measures for protecting vulnerable populations. Methods: A scoping review was conducted in accordance with PRISMA-ScR, covering peer-reviewed and credible grey literature in English up to 31 December 2024. Studies analysing bilateral, regional, or mega-regional FTAs with outcomes linked to health or equity were included. Thematic synthesis was organised around three predefined pathways. Results: Fifty-seven studies met inclusion criteria. TRIPS-plus and investor–state dispute settlement provisions consistently constrained access to medicines and deterred public-health regulation, with stronger adverse effects in low- and middle-income countries. Trade-driven food system shifts increased exposure to ultra-processed products, contributing to noncommunicable disease risks. Employment and environmental benefits were observed in select contexts, but impacts were uneven. COVID-19 revealed heightened equity challenges related to vaccine access and IP rules. Conclusion: FTAs shape structural conditions that influence health equity. Embedding health impact assessments, preserving TRIPS flexibilities, and protecting regulatory space are essential to ensure trade integration supports universal health coverage and the Sustainable Development Goals.
Downloads
References
Ribeiro H. Free-trade agreements: challenges for global health. Rev Saude Publica. 2015;49:52.
Labonté R. Trade, investment and public health: compiling the evidence, assembling the arguments. Global Health. 2019;15(1):1.
Silva L, Green L, Petchey L. Are free trade agreements trading away our health? Lessons from Public Health Wales’s health impact assessment of the Comprehensive and Progressive Agreement for Trans Pacific Partnership. Centre for Inclusive Trade Policy; 2023 Sep 11.
Islam MD, Kaplan WA, Trachtenberg D, Thrasher R, Gallagher KP, Wirtz VJ. Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review. Global Health. 2019;15(1):88.
American Public Health Association. Ensuring that trade agreements promote public health [Policy statement]. Washington (DC): APHA; 2015.
Shaffer ER, Waitzkin H, Brenner J, Jasso-Aguilar R. Global trade and public health. Am J Public Health. 2005;95(1):23-34.
Barlow P, McKee M, Stuckler D. The Impact of U.S. Free Trade Agreements on Calorie Availability and Obesity: A Natural Experiment in Canada. Am J Prev Med. 2018;54(5):637-643.
Adu DT, Sawadgo WPM, Li W. US trade policy and public health: heterogeneous effects from the North American Free Trade Agreement. Public Health Nutr. 2024;27(1):e165.
Sánchez-Ortiz NA, Unar-Munguía M, Bautista-Arredondo S, Shamah-Levy T, Colchero MA. Changes in apparent consumption of staple food in Mexico associated with the gradual implementation of the NAFTA. PLOS Glob Public Health. 2022;2(11):e0001144.
Lin TK, Teymourian Y, Tursini MS. The effect of sugar and processed food imports on the prevalence of overweight and obesity in 172 countries. Global Health. 2018;14(1):35.
Liu Z, Chen Q, Liu G, Han X. Do Deep Regional Trade Agreements Improve Residents' Health? A Cross-Country Study. Int J Environ Res Public Health. 2022;19(21):14409.
Schram A, Labonté R, Sanders D. Urbanization and international trade and investment policies as determinants of noncommunicable diseases in Sub-Saharan Africa. Prog Cardiovasc Dis. 2013 Nov-;56(3):281-301.
Park SP, Lee HJ, Yu Y, Lee EYJ, Park YS. Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity. BMJ Glob Health. 2023;8(11):e013669.
Son KB. Do Free Trade Agreements Matter to Drug Lag? Recent Evidence From Korea After the Korea-U.S. Free Trade Agreement. Int J Health Serv. 2020;50(2):147-155.
Son KB, Lopert R, Gleeson D, Lee TJ. Moderating the impact of patent linkage on access to medicines: lessons from variations in South Korea, Australia, Canada, and the United States. Global Health. 2018;14(1):101.
Jolin JR, Kim L, Vázquez-Velázquez V, Stanford FC. Re-evaluating obesity in Mexico-lessons for the global obesity epidemic. Lancet Diabetes Endocrinol. 2023;11(1):5-6.
Downloads
Published
How to Cite
License
Copyright (c) 2025 Om Prakash Bera, Venkatesh U, Deepankar Satapathy, Arshdeep Singh, Mokshada Chandge
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
